Opening book details…
About this Medicine article
Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial by Reddy, K Rajender; Zeuzem, Stefan; Zoulim, Fabien; Weiland, Ola; Horban, Andrzej; Stanciu, Carol; Villamil, Federico Guillermo; Andreone, Pietro; George, Jacob; Dammers, Elisabeth; Fu, Min; Kurland, Darryl; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; Verbinnen, Thierry; Scott, Jane; Jessner, Wolfgang is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Reddy, K Rajender; Zeuzem, Stefan; Zoulim, Fabien; Weiland, Ola; Horban, Andrzej; Stanciu, Carol; Villamil, Federico Guillermo; Andreone, Pietro; George, Jacob; Dammers, Elisabeth; Fu, Min; Kurland, Darryl; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; Verbinnen, Thierry; Scott, Jane; Jessner, Wolfgang
- Publisher
- The Lancet; Elsevier ; The Lancet Publishing Group; Elsevier BV; ScienceOpen (ISSN 1473-3099)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)